K
15 topics · 142 sources

Topics

Explore the strategic landscape. Each topic aggregates dozens of sources into one synthesised view.

Technology +78

Artificial Intelligence

Generative and agentic AI are moving from pilots to production. Compute, energy and governance are the emerging bottlenecks.

Sources
142
Pubs
918
Consensus
86
Open topic
Technology +62

Robotics

Humanoid and industrial robotics accelerated by foundation models.

Sources
74
Pubs
312
Consensus
68
Open topic
Technology +55

Cybersecurity

AI-augmented offense forces a shift to identity-first, zero-trust postures.

Sources
96
Pubs
641
Consensus
81
Open topic
Life Sciences +48

Healthcare

GLP-1s and AI diagnostics reshape care economics.

Sources
88
Pubs
512
Consensus
74
Open topic
Technology +71

Semiconductors

AI demand tightens leading-edge capacity; geopolitics fragments supply.

Sources
102
Pubs
704
Consensus
89
Open topic
Sustainability +40

Climate

Adaptation spending overtakes mitigation in several regions.

Sources
121
Pubs
883
Consensus
79
Open topic
Industrials +65

Energy

AI datacenter load reshapes the electricity mix; nuclear returns.

Sources
110
Pubs
592
Consensus
83
Open topic
Industrials +33

Mobility

L4 robotaxis scale in constrained ODDs; EV growth normalises.

Sources
64
Pubs
288
Consensus
61
Open topic
Frontier +44

Space

Launch cost decline unlocks LEO connectivity and Earth observation.

Sources
51
Pubs
210
Consensus
66
Open topic
Financial Services +36

FinTech

Stablecoins and embedded finance capture regulated share.

Sources
72
Pubs
349
Consensus
58
Open topic
Industrials +29

Supply Chains

Regional near-shoring locks in for critical categories.

Sources
68
Pubs
305
Consensus
72
Open topic
Macro +58

Geopolitics

Export controls and industrial policy reshape technology flows.

Sources
130
Pubs
861
Consensus
77
Open topic
Frontier +42

Quantum

Error correction milestones shift PQC and materials timelines.

Sources
44
Pubs
178
Consensus
49
Open topic
Life Sciences +47

Biotechnology

Programmable biology and CRISPR therapeutics reach the clinic.

Sources
59
Pubs
224
Consensus
63
Open topic
Markets +22

Consumer

Value-seeking and premiumisation coexist; loyalty rewires around AI.

Sources
47
Pubs
198
Consensus
54
Open topic